The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

Despite not having the legal authority to do so, President Trump signed an executive order asking drug companies to lower prices in the US.

It’s unclear how quickly Americans will see lower prices and what authority the US government has to direct drug pricing in other countries.